Maryland Peripheral Neuropathy Center

Clinical Trials

A randomized, double-blind, placebo controlled CROSS-OVER study of the effectiveness of immune globulin intravenous (human), 10% (IGIV, 10%) for the treatment of multifocal motor neuropathy

Investigators at the University of Maryland are conducting a study on patients with multifocal motor neuropathy. We are recruiting participants at the Maryland site for a 15 month randomized trial to determine the safety and effectiveness of IGIV, 10% on the muscle weakness caused by MMN.

Patients will be reimbursed for the study and will receive free testing and study drug as part of this trial.

For more information on our studies, please call Ms. Denise Landrum at 410-706-6689 or e-mail her at CLandrum@som.umaryland.edu.

This page was last updated on: April 10, 2009.

For more information and/or to make an appointment with the Maryland Peripheral Neuropathy Center, please call 410-328-3100.

Email this Page

Print this Page

© 2009 University of Maryland Medical Center (UMMC). All rights reserved. UMMC is a member of the University of Maryland Medical System, 22 S. Greene Street, Baltimore, MD 21201. 1.800.492.5538 TDD: 1.800.735.2258
Physician Referral: 1.800.373.4111

Y	N
		Age 30-75 years
		Prediabetes or early controlled diabetes less than 2 years
		Otherwise medically stable
		Have no other cause for neuropathy other than prediabetes or diabetes
		Walk independently without an assistive device
		Willing to travel to Baltimore for measurement sessions. This will occur approximately 4-5 times during the 12 month period.
		Willing to complete weekly self-report questionnaires
		Willing to accept assignment to either training group
		Willing and able to increase activity level and exercise independently at home